Stephen J. Nicholls
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
2020/08/28 by Milton Packer, Stefan D. Anker, Javed Butler +36 · 31 citations
Medicine · #Diabetes Treatment and Management #Hyperglycemia and glycemic control in critically ill and hospitalized patients #Renal Transplantation Outcomes and Treatments
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
2021/08/27 by Stefan D. Anker, Javed Butler, Gerasimos Filippatos +38 · 28 citations
Medicine · #Diabetes Treatment and Management #Hyperglycemia and glycemic control in critically ill and hospitalized patients #Pancreatic function and diabetes
- Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics
2023/09/25 by Stephen J. Nicholls, Deepak L Bhatt, Deepak L. Bhatt +29 · 32 citations
Medicine · #Diabetes Treatment and Management #Hyperglycemia and glycemic control in critically ill and hospitalized patients #Diabetes, Cardiovascular Risks, and Lipoproteins
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
2020/01/08 by Jan Borén, M. John Chapman, M John Chapman +48 · 1 voice · 7 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Atherosclerosis and Cardiovascular Diseases #Cancer, Lipids, and Metabolism #Lipoproteins and Cardiovascular Health
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
2020/11/15 by Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia +19 · 8 citations
Nursing · Medicine · #Fatty Acid Research and Health #Lipoproteins and Cardiovascular Health #Natural Products and Biological Research
- Factors underlying regression of coronary atheroma with potent statin therapy
2013/05/03 by Rishi Puri, Steven E. Nissen, Christie M. Ballantyne +11 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer, Lipids, and Metabolism #Coronary Interventions and Diagnostics #Lipoproteins and Cardiovascular Health
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
2017/09/12 by Brian A. Ference, John J. P. Kastelein, Henry N. Ginsberg +12 · 1 citation
- Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
2025/04/04 by Leslie Cho, Stephen J. Nicholls, Børge G. Nordestgaard +12 · 25 citations
Medicine · Immunology and Microbiology · #Lipoproteins and Cardiovascular Health #Atherosclerosis and Cardiovascular Diseases #Peripheral Artery Disease Management